Status:
ACTIVE_NOT_RECRUITING
Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Body Mass Index 25 or Greater
BRCA1 Gene Mutation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This pilot clinical trial studies different types of energy balance interventions to see how well they work in increasing the physical activity levels of breast cancer gene-positive patients, Lynch sy...
Detailed Description
PRIMARY OBJECTIVES: I. To explore the feasibility of using the multi-phase optimization strategy (MOST) approach to optimize energy balance (EB) interventions in a sample of MD Anderson employees. (P...
Eligibility Criteria
Inclusion
- PILOTS I, II AND III: Body mass index (BMI) of 25 or higher OR \< 150 minutes of moderate to vigorous exercise per week OR \< 5 servings of fruit and vegetables per day
- PILOTS I, II AND III: Capable of participating in moderate-vigorous unsupervised exercise
- PILOTS I, II AND III: Have a cellular telephone and are able and willing to send and receive text messages
- PILOTS I, II AND III: Able to read and write English
- PILOTS I, II AND III: Have access to internet
- PILOT II: BRCA positive OR Lynch syndrome positive individuals
- PILOT II (FAMILY MEMBER): Female and male biological and non-biological family members of BRCA-positive individuals OR Lynch syndrome positive individuals
- PILOT III: CLL survivors
- PILOT III: Has experienced fatigue within the past seven days
Exclusion
- PILOTS I, II AND III: Unable to walk without crutches, walker, cane, or other assistive device
- PILOTS I, II AND III: Women who are pregnant (by self-report)
- PILOTS I, II AND III: Less than 3 months post-surgery
- PILOTS II and III: Currently receiving radiation therapy or cytotoxic chemotherapy
Key Trial Info
Start Date :
September 17 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2027
Estimated Enrollment :
337 Patients enrolled
Trial Details
Trial ID
NCT02194387
Start Date
September 17 2014
End Date
September 30 2027
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030